Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Robert Meers
2. Date of Event Requiring Statement (Month/Day/Year)
07/26/2007
3. Issuer Name and Ticker or Trading Symbol
lululemon athletica inc. [LULU]
(Last)
(First)
(Middle)
C/O LULULEMON ATHLETICA, 2285 CLARK DRIVE
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Executive Officer
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

VANCOUVER, A1 V5N 3G9
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   (1) 01/26/2016 Common Stock 501,802 (2) $ 0.49 (2) D  
Stock Option (Right to Buy)   (1) 01/26/2016 Common Stock 2,285,422 (3) $ 0.6 (3) D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Robert Meers
C/O LULULEMON ATHLETICA
2285 CLARK DRIVE
VANCOUVER, A1 V5N 3G9
  X     Chief Executive Officer  

Signatures

/s/ Robert Meers 07/26/2007
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These options are 25% vested as of the date hereof and will vest in equal installments on each of January 27, 2008, January 27, 2009 and January 27, 2010.
(2) Mr. Meers has an option to purchase 1,170,000 shares of common stock of the Issuer's subsidiary, Lululemon Athletica USA Inc., at an exercise price of $0.21 per share. The option will be exchanged in a corporate reorganizaiton of the Issuer in connection with the Issuer's initial public offering, for (i) an option to purchase the number of shares of the Issuer's common stock shown in the table, at the exercise price shown in the table, and (ii) an additional option to purchase shares of the Issuer's common stock that vests based on the achievement of certain performance-based objectives and which accordingly does not constitute a "derivative security" within the meaning of Section 16.
(3) Mr. Meers has an option to purchase 1,170,000 shares of common stock of the Issuer's subsidiary, Lululemon Athletica, Inc., at an exercise price of $1.18 per share. The option will be exchanged in a corporate reorganization of the Issuer for (i) an option to purchase the number of shares of the Issuer's common stock shown in the table, at the exercise price shown in the table, and (ii) an additional option to purchase shares of the Issuer's common stock that vests based on the achievement of certain performance-based objectives and which accordingly does not constitute a "derivative security" within the meaning of Section 16.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.